Across TCGA pan-cancer cohorts, VN1R11P RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of VN1R11P’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where VN1R11P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types VN1R11P is over-expressed in tumor.

KIRC, BRCA, and PRAD are the cancer types where VN1R11P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in VN1R11P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	All	+0.063	<.001	4	view →
BRCA	All	All	+0.010	.032	4	view →
PRAD	All	All	+0.025	<.001	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: VN1R11P RNA expression & survival · all VN1R11P data types